Marco is a Principal in the Healthcare team. He joined Apax in 2016 and is currently based in London. Marco has participated in key deals, including Engineering Group, Neuraxpharm, Unilabs and Rodenstock.
Prior to joining Apax, Marco was a Business Analyst at McKinsey & Company in their Milan office.
Marco holds an MBA from Harvard Business School, an MSc and BSc in Materials Engineering from Politecnico di Milano summa cum laude and an MSc in Materials Engineering from Politecnico di Torino summa cum laude.
Marco serves on the board of Unilabs and previously served on the board of Engineering Group.
Marco’s attraction to private equity investment stems from his avid curiosity, which allows him to enjoy and thrive in the intellectually stimulating process of understanding how businesses really work. Marco chose Apax for its approach to investments: go beyond financial engineering to a real strategy of value creation for the funds' portfolio companies, which allows it to re-shape leading players in a variety of industries while maintaining a sense of responsibility for their employees and communities.